FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%
Rituximab for Children with Lupus Nephritis
ACR Responds to 2022 Medicare Physician Fee Schedule Proposed Rule
Vasculitis Guidelines in Focus, Part 3: EGPA
Rheum After 5: Dr. David Isenberg, Rheumatologist & Bandleader
New Editor Looks to Strengthen AC&R’s Connections to Clinical Care
Summer 2021’s Awards, Appointments & Announcements in Rheumatology
HIPAA and PHI Cybersecurity Best Practices in the COVID-19 Era
Using Different Fibromyalgia Criteria Affects Prevalence Estimates
- 1
- 2
- 3
- …
- 684
- Next Page »